
Senior Scientist-II, Genomics - Precision Medicine @AbbVie | Ph.D. from @LifeAtPurdue | Developing drugs against #cancer |🇧🇩🇺🇸
South San Francisco
Joined March 2013
- Tweets859
- Following721
- Followers217
- Likes2.8K
Saeed Salehin Akhand retweeted
Great to the see the flurry of single gene knockdown Perturb-seq like atlases from cell-lines, mouse brain etc over the last few days. These are undoubtedly very valuable datasets. I just want to re-iterate a few other very important expt. design considerations 1/
Saeed Salehin Akhand retweeted
First announced patient dosing of an in vivo prime editing treatment (to correct ATP7B H1069Q, one of the most common genetic causes of Wilson disease). There are now at least three prime editing clinical trials underway—for CGD (ex vivo, with positive clinical outcomes), for Wilson disease (in vivo), and for alpha-1 antitrypsin deficiency (AATD, in vivo).
We announced the first patient has been dosed in our global Phase 1/2 clinical trial of PM577a for H1069Q-mutated Wilson disease.
PM577 has also received FDA Rare Pediatric Disease designation.
Read more: tinyurl.com/mue7xe9e
#PrimeMedicine #WilsonDisease #GeneEditing
Saeed Salehin Akhand retweeted
I've attempted to map everything in oncology in a public website and open source repo for all.
The site is trying to get all cancers, products, technologies, bottlenecks, people, startup opportunities with 1000+ ideas for upgrading the field.
If you have a loved one with cancer and you are technical or can engineer, go take a look, file improvement requests or bugs or help with the open repo and make this the best open and free info resource for individuals, researchers and educational use.
This should save people time, aid AI oncology projects and generate positive action. If you are not technical just complain in this thread about broken or annoying or things you want and I'll fix them live.
Some of the interesting pages:
Treatments: onco.cc/drugs
A gallery of the molecules being used onco.cc/molecules/
And targets: onco.cc/targets/
The technologies in oncology: onco.cc/technologies/
1100 ideas for helping oncology: onco.cc/ideas/
Bottlenecks on oncology: onco.cc/bottlenecks/
Open questions (LETS GO RESEARCH PEOPLE) onco.cc/open-questions/
Startup requests (LETS GO STARTUP PEOPLE) onco.cc/startup-requests/
Mechanics of cancer: onco.cc/mechanics
Battlefronts: onco.cc/fronts/
Isotope supply: onco.cc/isotopes
Key papers: onco.cc/key-papers
Pipeline funnels: onco.cc/pipeline
Cancer by type: onco.cc/cancers/
Institutional rankings: onco.cc/institutions/
The startups: onco.cc/startups/
Heros and heroines : onco.cc/heroes/
Key medical people: onco.cc/people/
Here is the project roadmap: onco.cc/roadmap/
Models and data sets: onco.cc/models/
There are other views as well, take a browse.
Try making a PR if you have an upgrade to this on the repo here: github.com/judegomila/OnCo
If you are biologically/medically minded and something is wrong, file a bug as well or say on the thread and we will get it fixed live.
If this is a useful project star the repo and help get it calibrated.
I've tried to add some other languages but I cannot speak them so tell me if that doesnt work well.
I believe we will crack oncology and having total information dominance is key to the problem.
Let the feedback flow!
Saeed Salehin Akhand retweeted
Over the past few months, we've been rewriting core workflows in Seurat with coding agents to improve speed and scalability. By moving steps from R to C++ and optimizing code, we've seen huge improvements - in some cases 10-fold and above - with identical outputs. (1/)
Saeed Salehin Akhand retweeted
🔥Genomics of aging in @Nature !!🔥
nature.com/articles/s41586-0…
Saeed Salehin Akhand retweeted
Arguably the most boring step in genomics is the first one: normalization. Settled science. Scale + log. Move on.
Except that here's been a huge blind spot in the field. And it matters for AIxBio. A 🧵about what I think may be one of the most important papers I've written. 1/
Saeed Salehin Akhand retweeted
LaaS: Logistics as a Service
Wake up babe, new category just dropped
TODAY: Amazon is opening its entire logistics network—freight, distribution, fulfillment, and parcel shipping capabilities—to every business, of all types and sizes. 📦
Amazon has built one of the most reliable and efficient supply chains on Earth. Now, Amazon Supply Chain Services gives all businesses access to the same infrastructure that moves, stores, and ships goods for hundreds of thousands of Amazon sellers.
Healthcare, automotive, manufacturing, retail, and more. Businesses across industries can now tap into Amazon's logistics network. Learn more here. ⬇️
Saeed Salehin Akhand retweeted
Worrying that your startup will be eaten by the model companies is like worrying that your life will be constrained after you become a movie star. You're far more likely simply to fail.
Saeed Salehin Akhand retweeted
Actually, your analysis might fail regardless of which you picked. But one thing is for sure: your analysis will be very different depending on the choice. sciencedirect.com/science/ar…
Replying to @tangming2005
9/ For single-cell: Use Seurat if you're in R. Use Scanpy if you're in Python. Both work. Your analysis won't fail because you picked one over the other.
Saeed Salehin Akhand retweeted
Eid Mubarak to all! 🌙 I hope you have a very special day with your family and loved ones. Wishing you all peace and happiness.
Saeed Salehin Akhand retweeted
Today we report single-cell APEX-seq (scAPEX-seq) — a new method for unbiased mapping of *subcellular* transcriptomes at single-cell resolution. This approach reveals cell states that are not detectable by standard scRNA-seq, and enabled us to identify regulators of CAR T function that improve solid tumor killing.
biorxiv.org/cgi/content/shor…




































